Junshi Biosciences Announces JAMA Publication of Results from NEOTORCH, a Randomized Phase 3 Trial of Perioperative Toripalimab plus Chemotherapy for Patients with Resectable Non-Small Cell Lung Cancer

SHANGHAI, China, Jan. 17, 2024 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced the publication of results from the prespecified interim analysis for event-free survival (EFS) in patients with stage III non-Small Cell […]

Read More

e2Companies Secures $100 Million Investment Commitment from GEM, as Company Anticipates Listing

Investment Commitment will Fund e2Companies’ Future Growth and Virtual Utility® BONITA SPRINGS, Fla., Jan. 17, 2024 (GLOBE NEWSWIRE) — e2Companies, a leading provider of integrated solutions for power generation and distribution, announced today that it has secured a $100 million investment commitment from Luxembourg based Global Emerging Markets (“GEM”). With this financing commitment, e2Companies is […]

Read More

Fluence Surpasses 20 GWh of Deployed and Contracted Battery-based Energy Storage Systems Globally

This industry-leading milestone marks a new era of scale in battery energy storage and underscores the critical role of storage in enabling the energy transition and reducing the cost of clean and reliable power ARLINGTON, Va., Jan. 17, 2024 (GLOBE NEWSWIRE) — Fluence Energy, Inc. (“Fluence”) (NASDAQ: FLNC), a leading global provider of energy storage […]

Read More

Nyxoah Announces 2024 Strategic Priorities

Nyxoah Announces 2024 Strategic Priorities Mont-Saint-Guibert, Belgium – January 17, 2024, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced, in anticipation of upcoming investor meetings, its strategic […]

Read More